Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Non-Current Assets (2024 - 2026)

Kestra Medical Technologies (KMTS) reported Non-Current Assets of $65.3 million for Q1 2026, up 71.43% year-over-year from $38.1 million in Q1 2025, and up 27.28% on a QoQ basis from $51.3 million in Q4 2025.

Kestra Medical Technologies (KMTS) has 3 years of Non-Current Assets data on file, last reported at $65.3 million in Q1 2026.

  • Quarterly Non-Current Assets rose 71.43% year-over-year to $65.3 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $202.6 million (changed N/A YoY) and the FY2025 annual result came in at $40.4 million, up 30.2% from the prior year.
  • Non-Current Assets advanced to $65.3 million in Q1 2026 per KMTS's latest filing, from $51.3 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $65.3 million in Q1 2026 and bottomed at $31.0 million in Q2 2024.
  • The 3-year median for Non-Current Assets is $43.0 million (2025), against an average of $45.3 million.
  • The widest annual swing landed in 2025, when Non-Current Assets jumped 30.2%; it then soared 71.43% in 2026.
  • Tracing KMTS's Non-Current Assets over 3 years: stood at $31.0 million in 2024, then surged by 65.22% to $51.3 million in 2025, then grew by 27.28% to $65.3 million in 2026.
  • Per Business Quant, the three latest KMTS Non-Current Assets figures stand at $65.3 million (Q1 2026), $51.3 million (Q4 2025), and $45.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 11.30 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 42.82 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 4.72 Bn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 2.28 Bn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 10.51 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 10.29 Bn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 3.66 Bn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 13.00 Bn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 3.33 Bn
10 Kestra Medical Technologies 1.13 Bn 840.05 Mn 12.91 Mn 65.28 Mn

Historic Data

Download Data 🔒
DateValue
Jan 31, 2026 65.28 Mn
Oct 31, 2025 51.29 Mn
Jul 31, 2025 45.61 Mn
Apr 30, 2025 40.42 Mn
Jan 31, 2025 38.08 Mn
Apr 30, 2024 31.04 Mn